Harrow Inc (HROW)
16.76
+0.60
(+3.71%)
USD |
NASDAQ |
May 17, 16:00
16.77
+0.01
(+0.06%)
After-Hours: 20:00
Harrow 1 Year Total Returns (Daily): -22.44% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -22.44% |
May 16, 2024 | -23.19% |
May 15, 2024 | -23.77% |
May 14, 2024 | -26.32% |
May 13, 2024 | -45.24% |
May 10, 2024 | -58.17% |
May 09, 2024 | -63.35% |
May 08, 2024 | -62.20% |
May 07, 2024 | -59.63% |
May 06, 2024 | -61.29% |
May 03, 2024 | -59.28% |
May 02, 2024 | -58.45% |
May 01, 2024 | -59.67% |
April 30, 2024 | -59.61% |
April 29, 2024 | -57.91% |
April 26, 2024 | -57.69% |
April 25, 2024 | -58.59% |
April 24, 2024 | -59.29% |
April 23, 2024 | -58.10% |
April 22, 2024 | -56.96% |
April 19, 2024 | -55.53% |
April 18, 2024 | -54.12% |
April 17, 2024 | -49.16% |
April 16, 2024 | -43.94% |
April 15, 2024 | -43.71% |
Date | Value |
---|---|
April 12, 2024 | -42.97% |
April 11, 2024 | -42.43% |
April 10, 2024 | -45.07% |
April 09, 2024 | -42.31% |
April 08, 2024 | -42.31% |
April 05, 2024 | -36.66% |
April 04, 2024 | -38.18% |
April 03, 2024 | -37.53% |
April 02, 2024 | -41.49% |
April 01, 2024 | -39.51% |
March 28, 2024 | -37.68% |
March 27, 2024 | -40.68% |
March 26, 2024 | -31.70% |
March 25, 2024 | -34.85% |
March 22, 2024 | -33.41% |
March 21, 2024 | -41.32% |
March 20, 2024 | -39.37% |
March 19, 2024 | -38.65% |
March 18, 2024 | -39.57% |
March 15, 2024 | -39.68% |
March 14, 2024 | -45.71% |
March 13, 2024 | -42.03% |
March 12, 2024 | -40.70% |
March 11, 2024 | -40.25% |
March 08, 2024 | -41.16% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.35%
Minimum
May 09 2024
359.6%
Maximum
May 11 2023
45.31%
Average
20.77%
Median
Oct 19 2023
1 Year Total Returns (Daily) Benchmarks
Durect Corp | -82.45% |
Aquestive Therapeutics Inc | 51.71% |
Cyclacel Pharmaceuticals Inc | -76.51% |
Stereotaxis Inc | 24.26% |
Cara Therapeutics Inc | -82.12% |